Congratulations to Kalpana Sharma on successfully defending her PhD thesis at Paracelsus Medizinische Privatuniversität (PMU) Salzburg. She presented her work on March 2nd, 2026, with Marianne Hollensteiner (Biomechanik Murnau) as Chair, and Andreas Seitz (Ulm) and Bodo Kurz (Kiel) as external examiners. Kalpana is an Assistant Professor at the Institute of Anatomy (headed by Prof. … Continued
The redesigned Chondrometrics Website and its flyer are now live, ready to be explored. Both media products showcase who Chondrometrics is, what they do, and the science behind it: Quantitative image analysis, biomarker qualification, and surrogate endpoint development – in support of academic research as well as clinical trials. A great thanks to Sharif Karimi … Continued
We are overly happy that our review on: “Advances in Cartilage Imaging Techniques”, including Felix Eckstein and Wolfgang Wirth as authors, has just been published in Nature Reviews Rheumatology (NRR) https://pubmed.ncbi.nlm.nih.gov/41634466/. This poly-author article covers the following areas: Introduction – MRI technique – semiquantitative MRI – cartilage assessment – cartilage morphometry – high field (3 … Continued
After announcing the company’s participation in the IHI-PROBE (Patient Relevant Osteoarthritis endpoints using Big data Evaluation) project, launched on December 1st, 2025, it’s a great pleasure to now meet the participants This pioneering initiative under the Innovative Health Initiative Joint Undertaking (IHI JU) represents a large-scale public-private partnership to revolutionise the way osteoarthritis (OA) is … Continued
Chondrometrics authors publish a review on clinical validation of automated AI based segmentation of articular tissues in a special issue of Osteoarthritis Cartilage Open, with reference to two recently published original articles by the group. Chondrometrics’ CEO Wolfgang Wirth, and former team and now SAB member Jana Eder, have just published a review in which … Continued
As of January 1st, 2026 , Wolfgang Wirth has officially assumed the role of the CEO, taking over from Felix Eckstein. This represents important steps in the evolution of the company’s leadership and its team. Wolfgang has been part of Chondrometrics since its foundation in 2003 and has shaped the company in an unparalleled manner. … Continued
APPROACH (Applied Public-Private Research enabling OsteoArthritis Clinical Headway) was a European Innovative Medicines Initiative (IMI) project designed to improve stratification and prediction of progression in knee osteoarthritis (OA). By integrating imaging, clinical parameters, biochemical markers and machine learning in 300 participants followed over 2 years, the APPROACH consortium established one of the most deeply phenotyped … Continued
With the year ending, it is time to reflect what has been achieved in 2025 Thanks to our industry and academic partners, our pipeline was well filled, with several large and small clinical trials making great progress. Thanks for the hard work performed by our team, and for driving these projects. The data produced by … Continued
ACR Open Rheumatol. 2025 Sep;7(9):e70085 https://pubmed.ncbi.nlm.nih.gov/40977252/ With Jamie Collins from Harvard University and Chondrometrics SAB member as a first author, the 2nd large osteoarthritis biomarker consortium qualification project that was supported by the Foundation of the National Institutes of Health (FNIH), has now been published: The goal was to validate MRI-based prognostic biomarkers using data … Continued
The Chondrometrics SAB met between October 11 and 15, 2025. It was a most inspiring week, where science, technology, and team spirit met in Freilassing and beyond. After the Symposium of the Nationale Akademie der Wissenschaften “Leopoldina” on Skeletal Interfaces, and a scenic conference tour to the Untersberg, the SAB meeting started in the afternoon … Continued